Omega Announces Third Quarter Earnings Release Date and Conference Call

Rhea-AI Summary

Omega Healthcare Investors, Inc. (NYSE:OHI) to release Q3 2023 earnings results on November 2, 2023, after market close. Conference call scheduled for November 3, 2023, at 10 a.m. ET to review results and current developments.

HUNT VALLEY, Md.--(BUSINESS WIRE)-- Omega Healthcare Investors, Inc. (NYSE:OHI) announced today that it is scheduled to release its earnings results for the quarter ended September 30, 2023, on Thursday, November 2, 2023, after market close. In conjunction with its release, Omega will be conducting a conference call on Friday, November 3, 2023, at 10 a.m. Eastern Time to review its 2023 third quarter results and current developments.

To listen to the conference call via webcast, log on to www.omegahealthcare.com and click the “3Q 2023 Earnings Call” hyperlink on the “Investors” page of Omega’s website. Webcast replays of the call will be available on Omega’s website for approximately two weeks following the call. Additionally, a copy of the earnings release will be available in the “Financial Information” section on the “Investors” page of Omega’s website.

Analysts and investors within the United States interested in participating are invited to call (877) 407-9124. The international toll-free dial-in number is (201) 689-8584. Ask the operator to be connected to the “Omega Healthcare Third Quarter 2023 Earnings Call.”

Omega is a real estate investment trust that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the US, as well as in the UK. More information on Omega is available at www.omegahealthcare.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20231004093296/en/

David Griffin, Director, Corporate Strategy & Investor Relations, at (410) 427-1705

Source: Omega Healthcare Investors, Inc.